Trial NCT05728372

View at ClinicalTrials.gov 
Org. Study IDs: 22305
Secondary IDs: 22305 NCI-2022-10254 P30CA033572

Last trial update was posted on 2023-10-10

MeSH Interventions

Copper Pembrolizumab

MeSH Conditions


Other Conditions

Metastatic Malignant Solid Neoplasm

Stopping Reasons

withdrawn per PI

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID